Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Ministry of Health and WelfareRegulator guidanceLot release and sample testingBiologicsHigh confidenceLast verified October 5, 2026

Taiwan biological product lot release regulations

Regulations for Lot Release and Sealing of Biological Products

Current edition

Amended July 15, 2015

About this standard

Covers serums, antitoxins, vaccines, toxoids and bacterial preparations made on microbiological and immunological principles.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Taiwan

Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube